Farmas USA

negar la sanidad sea a quien sea (mucho más cruel al que no tiene) debería estar penado con la desmembración pública

Mientras no se afilie otro/a jajaja

Amarin Announces Mandatory Exchange of Exchangeable Senior Notes Issued in May 2014 and November 2015

BEDMINSTER, N.J. and DUBLIN, Ireland, Aug. 26, 2016 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) ("Amarin"), announced today that its wholly owned subsidiary, Corsicanto Limited, a private limited company incorporated under the laws of Ireland (the "Issuer"), provided notice that the Issuer has exercised its option to mandatorily exchange all $118.734 million in aggregate principal amount of its 3.50% May 2014 Exchangeable Senior Notes due 2032 (the "2014 Notes") into American Depositary Shares ("ADSs") of Amarin, with each ADS representing one ordinary share of Amarin. As a result, Amarin will issue 384.6154 ADSs per $1,000 principal amount of 2014 Notes, subject to certain adjustments as provided in the Indenture, dated May 20, 2014 by and among the Issuer, Amarin, and Wilmington Trust, National Association, as trustee (the "Indenture") governing the 2014 Notes.

Amarin also announced today that it provided notice of the exercise of Amarin's option to mandatorily exchange all $31.266 million in aggregate principal amount of its 3.50% November 2015 Exchangeable Senior Notes due 2032 (the "2015 Notes") into ADSs of Amarin, with each ADS representing one ordinary share of Amarin. As a result, Amarin will issue 384.6154 ADSs per $1,000 principal amount of 2015 Notes, subject to certain adjustments as provided in the 2015 Notes.

The mandatory exchange of the 2014 Notes will be effective on September 12, 2016. As a condition to the mandatory exchange under the Indenture, the daily volume weighted average pricing per ADS equaled or exceeded $2.86 for at least 20 trading days in the 30-trading-day period commencing on July 18, 2016 and ending on (and including) August 26, 2016. The date of notice of the exercise of Issuer's mandatory exchange option under the Indenture is August 26, 2016, and the "Optional Exchange Trigger Period" under the Indenture began on July 18, 2016 and ended on (and included) August 26, 2016. The aggregate principal amount of 2014 Notes subject to the Issuer's mandatory exchange option is $118,734,000. The CUSIP number of the 2014 Notes is 220480AB3. On and after the effective date of the exchange, interest on the 2014 Notes will cease to accrue. The name and address of the Paying Agent and Exchange Agent under the Indenture are as follows:

• Paying Agent: Wilmington Trust, National Association, 50 S. Sixth Street, Suite 1290, Minneapolis, MN 55402, Attention: Corsicanto Ltd. Account Manager, Facsimile:  612- 617-5651
• Exchange Agent: Wilmington Trust, National Association, 50 S. Sixth Street, Suite 1290, Minneapolis, MN 55402, Attention: Corsicanto Ltd. Account Manager, Facsimile:  612- 617-5651

The mandatory exchange of the 2015 Notes will be effective on September 12, 2016. As a condition to the mandatory exchange under the 2015 Notes, the daily volume weighted average pricing per ADS equaled or exceeded $2.86 for at least 20 trading days in the 30-trading-day period commencing on July 18, 2016 and ending on (and including) August 26, 2016. The date of notice of the exercise of Amarin's mandatory exchange option under the 2015 Notes is August 26, 2016, and the "Optional Exchange Trigger Period" under the 2015 Notes began on July 18, 2016 and ended on (and included) August 26, 2016. The aggregate principal amount of 2015 Notes subject to the Issuer's mandatory exchange option is $31,266,000. On and after the effective date of the exchange, interest on the 2015 Notes will cease to accrue. The name and address of the Paying Agent and Exchange Agent under the 2015 Notes are as follows:

• Paying Agent: Amarin Corporation plc, c/o Amarin Pharma Inc., 1430 US-206, Bedminster Township, NJ 07921, Attention: Chief Financial Officer
• Exchange Agent: Amarin Corporation plc, c/o Amarin Pharma Inc., 1430 US-206, Bedminster Township, NJ 07921, Attention: Chief Financial Officer

This announcement is neither an offer to sell nor a solicitation of an offer to buy any of these securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such offer, solicitation or sale is unlawful. The ADSs issuable upon exchange of the 2014 Notes and 2015 Notes will not be registered under the Securities Act of 1933, as amended (the "Securities Act"), or the securities laws of any other jurisdiction, and may not be offered or sold in the United States absent registration under the Securities Act or an applicable exemption from registration requirements.

IS NOVAVAX, INC. (NVAX) THE 'BEST IDEA' FOR CONTRARIANS?

http://www.schaeffersresearch.com/content/analysis/2016/08/26/is-novavax-inc-nvax-the-best-idea-for-contrarians

NVAX

Muy interesante, de hecho todos soñamos con ese short squeeze.

Gracias Framus.

La razon de estar fuera del mercado ahora ( ademas de estar hasta los huevos de la bajista que no supera NVAX ) fue por la abrupta caida activada/orquestada por Hillary tras un doble top, ese gap en 277 ... el soporte de canal si va a visitarlo de nuevo ... muchos demonios... pronto se vera ... 

Creo que la proxima semana se va a ver la verdadera cara del asunto, para donde va ...

IBB en diario y semanal

Creo que este grafico SEMANAL elimina ruido y se aprecia mejor las posibilidades

edito :

y se lo pinto tambien a los usanos "con colorines" para que lo comprendan mejor ...

Flipo, sin sanidad, a tomar por culo en art. 43 de la Constitución.

Parece que tenga más derecho que tú un ilegal que llegue a España. Este pais es tal Paraíso para los ilegales, que lo primero que hacen es buscar una comisaría para censarse y tener acceso a nuestro sistema, así que fíjate el miedo que les damos.

Te tienen sin sanidad, pero bien que te quitan la mitad de la cosecha cada año, menuda sinvergüencería.

ay ay ay que me estoy volviendo cada vez mas oso por momentos ...

NASDAQ COMPOSITE SEMANAL